Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

sagi habasov

1119 POSTS

Exclusive articles:

SKN | Tactical Resources Corp.: Critical Minerals Play Targets Public Market Expansion

Tactical Resources Corp. is positioning itself for greater investor visibility as demand for critical minerals reshapes the resource sector and strategic supply chains. The...

SKN | Guggenheim Funds Trust: ETF Platform Draws Investor Attention

Guggenheim Funds Trust is drawing attention as investors assess its role in the expanding exchange-traded fund market and the potential implications of new fund...

SKN | SPAC Southern Cross Acquisition II Cuts Unit Offering 25% Ahead of $75 Million IPO

Southern Cross Acquisition II, a blank check company led by Chinese media entrepreneur Ally Zhang, has reduced the size of its proposed initial public...

SKN | Lyntris Inc.: IPO Plans Put Oncology Innovation Under Investor Scrutiny

Lyntris Inc. is emerging as a biotechnology company to watch as investors assess its potential public-market debut and the capital it could raise to...

SKN | Hong Kong-Based Living Homeopathy International Withdraws $19 Million US IPO

Living Homeopathy International, a Hong Kong-based company selling homeopathic products, has withdrawn its plans for an initial public offering in the United States. The...

Breaking

SKN | Sensing4D AI Files for $35 Million US IPO to Expand 3D Vision Technology

Sensing4D AI, a China-based provider of artificial intelligence-powered 3D...

SKN | IPO Momentum | U.S. IPO Calendar Expands as Nine Offerings Target October 21

Key Takeaways: Nine expected IPO pricings were listed for...

SKN | Lycia Therapeutics Sets Terms for $250 Million IPO to Advance Protein-Degrading Therapies

Lycia Therapeutics, a clinical-stage biotechnology company developing protein-degrading therapies...

SKN | Spyre Therapeutics Shares Surge 7.88% Ahead of November Earnings Report

Spyre Therapeutics, Inc. (NASDAQ: SYRE) shares rose 7.88% to...
spot_imgspot_img